Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Roberta Jorgensen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
45
Lindor, Keith
21
Angulo, Paul
21
Dickson, Rolland
9
Keach, Jill
6
Therneau, Terry
5
Petz, Janice
5
Talwalkar, Jayant
4
Wiesner, Russell
4
Hofmann, Alan
4
DeSotel, CK
3
Crippin, Jeffrey
3
Cauch-Dudek, Karen
3
Harnois, Denise
3
Heathcote, Jenny
3
Kowdley, Kris
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Roberta Jorgensen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lindor Keith D; Kowdley Kris V; Luketic Velimir A C; Harrison M Edwyn; McCashland Timothy; Befeler Alex S; Harnois Denise; Jorgensen Roberta; Petz Jan; Keach Jill; Mooney Jody; Sargeant Carol; Braaten Julie; Bernard Tamara; King Debra; Miceli Ellen; Schmoll Jeff; Hoskin Tanya; Thapa Prabin; Enders Felicity
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Hepatology (Baltimore, Md.) 2009;50(3):808-14.
-
2008: Jorgensen Roberta
Chronic fatigue: an evolutionary concept analysis.
Journal of advanced nursing 2008;63(2):199-207.
-
2008: Angulo Paul; Jorgensen Roberta A; Kowdley Kris V; Lindor Keith D
Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.
Digestive diseases and sciences 2008;53(6):1716-20.
-
2007: Talwalkar Jayant A; Gossard Andrea A; Keach Jill C; Jorgensen Roberta A; Petz Janice L; Lindor R N Keith D
Tacrolimus for the treatment of primary sclerosing cholangitis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(4):451-3.
-
2007: Charatcharoenwitthaya Phunchai; Levy Cynthia; Angulo Paul; Keach Jill; Jorgensen Roberta; Lindor Keith D
Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(2):220-6.
-
2006: Talwalkar Jayant A; Donlinger Jessica J; Gossard Andrea A; Keach Jill C; Jorgensen Roberta A; Petz Janice C; Lindor Keith D
Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.
Digestive diseases and sciences 2006;51(11):1985-91.
-
2006: Mendes Flavia D; Jorgensen Roberta; Keach Jill; Katzmann Jerry A; Smyrk Thomas; Donlinger Jessica; Chari Suresh; Lindor Keith D
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
The American journal of gastroenterology 2006;101(9):2070-5.
-
2005: Zein Claudia O; Jorgensen Roberta A; Clarke Bart; Wenger Doris E; Keach Jill C; Angulo Paul; Lindor Keith D
Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.
Hepatology (Baltimore, Md.) 2005;42(4):762-71.
-
2005: Levy Cynthia; Harnois Denise M; Angulo Paul; Jorgensen Roberta; Lindor Keith D
Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(1):117-21.
-
2005: Talwalkar Jayant A; Angulo Paul; Keach Jill C; Petz Janice L; Jorgensen Roberta A; Lindor Keith D
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Journal of clinical gastroenterology 2005;39(2):168-71.
-
2005: Talwalkar Jayant A; Angulo Paul; Keach Jill C; Petz Janice L; Jorgensen Roberta A; Lindor Keith D
Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2005;100(2):308-12.
-
2004: Lindor Keith D; Kowdley Kris V; Heathcote E Jenny; Harrison M Edwyn; Jorgensen Roberta; Angulo Paul; Lymp James F; Burgart Lawrence; Colin Patrick
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Hepatology (Baltimore, Md.) 2004;39(3):770-8.
-
2003: Siegel Joanna L; Jorgensen Roberta; Angulo Paul; Lindor Keith D
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis.
Journal of clinical gastroenterology 2003;37(2):183-5.
-
2003: Talwalkar Jayant A; Souto Enrico; Jorgensen Roberta A; Lindor Keith D
Natural history of pruritus in primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(4):297-302.
-
2003: Jorgensen Roberta A
Nonalcoholic Fatty liver disease.
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 2003;26(4):150-4; quiz 154-5.
-
2002: Jorgensen Roberta; Angulo Paul; Dickson E Rolland; Lindor Keith D
Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
The American journal of gastroenterology 2002;97(10):2647-50.
-
2002: Suzuki Ayako; Van de Water Judy; Gershwin M Eric; Jorgensen Roberta; Angulo Paul; Lindor Keith
Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis.
Developmental immunology 2002;9(2):55-61.
-
2002: Joshi Supriya; Cauch-Dudek Karen; Heathcote E Jenny; Lindor Keith; Jorgensen Roberta; Klein Reinhild
Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
The American journal of gastroenterology 2002;97(4):999-1002.
-
2002: Joshi Supriya; Cauch-Dudek Karen; Wanless Ian R; Lindor Keith D; Jorgensen Roberta; Batts Kenneth; Heathcote E Jenny
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2002;35(2):409-13.
-
2002: Angulo Paul; MacCarty Robert L; Sylvestre Pamela B; Jorgensen Roberta A; Wiesner Russell H; LaRusso Nicholas A; Lindor Keith D
Pirfenidone in the treatment of primary sclerosing cholangitis.
Digestive diseases and sciences 2002;47(1):157-61.
-
2001: Angulo P; Jorgensen R A; Lindor K D
Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
The American journal of gastroenterology 2001;96(11):3152-7.
-
2001: Abdelmalek M F; Angulo P; Jorgensen R A; Sylvestre P B; Lindor K D
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study.
The American journal of gastroenterology 2001;96(9):2711-7.
-
2001: Harnois D M; Angulo P; Jorgensen R A; Larusso N F; Lindor K D
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
The American journal of gastroenterology 2001;96(5):1558-62.
-
2000: Lindor K D; Jorgensen R A; Tiegs R D; Khosla S; Dickson E R
Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial.
Journal of hepatology 2000;33(6):878-82.
-
2000: Kim W R; Lindor K D; Malinchoc M; Petz J L; Jorgensen R; Dickson E R
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease.
Hepatology (Baltimore, Md.) 2000;32(5):924-9.
-
2000: Angulo P; Patel T; Jorgensen R A; Therneau T M; Lindor K D
Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;32(5):897-900.
-
2000: Angulo P; Batts K P; Jorgensen R A; LaRusso N A; Lindor K D
Oral budesonide in the treatment of primary sclerosing cholangitis.
The American journal of gastroenterology 2000;95(9):2333-7.
-
2000: Angulo P; Jorgensen R A; Keach J C; Dickson E R; Smith C; Lindor K D
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology (Baltimore, Md.) 2000;31(2):318-23.
-
1999: Angulo P; Dickson E R; Therneau T M; Jorgensen R A; Smith C; DeSotel C K; Lange S M; Anderson M L; Mahoney D W; Lindor K D
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Journal of hepatology 1999;30(5):830-5.
-
1999: Angulo P; Lindor K D; Therneau T M; Jorgensen R A; Malinchoc M; Kamath P S; Dickson E R
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.
Liver 1999;19(2):115-21.
-
1999: Angulo P; Bharucha A E; Jorgensen R A; DeSotel C K; Sandborn W J; Larusso N F; Lindor K D
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.
Digestive diseases and sciences 1999;44(3):602-7.
-
1999: Angulo P; Batts K P; Therneau T M; Jorgensen R A; Dickson E R; Lindor K D
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(3):644-7.
-
1999: Pasha T; Heathcote J; Gabriel S; Cauch-Dudek K; Jorgensen R; Therneau T; Dickson E R; Lindor K D
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(1):21-6.
-
1998: Lindor K D; Lacerda M A; Jorgensen R A; DeSotel C K; Batta A K; Salen G; Dickson E R; Rossi S S; Hofmann A F
Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
The American journal of gastroenterology 1998;93(9):1498-504.
-
1998: Zukowski T H; Jorgensen R A; Dickson E R; Lindor K D
Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy.
The American journal of gastroenterology 1998;93(6):958-61.
-
1998: Ricci P; Hofmann A F; Hagey L R; Jorgensen R A; Rolland Dickson E; Lindor K D
Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
Digestive diseases and sciences 1998;43(6):1292-5.
-
1996: Lindor K D; Therneau T M; Jorgensen R A; Malinchoc M; Dickson E R
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis.
Gastroenterology 1996;110(5):1515-8.
-
1996: Lindor K D; Jorgensen R A; Anderson M L; Gores G J; Hofmann A F; LaRusso N F
Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.
The American journal of gastroenterology 1996;91(3):511-5.
-
1995: Lindor K D; Dickson E R; Jorgensen R A; Anderson M L; Wiesner R H; Gores G J; Lange S M; Rossi S S; Hofmann A F; Baldus W P
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1158-62.
-
1995: Jorgensen R A; Dickson E R; Hofmann A F; Rossi S S; Lindor K D
Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.
Gut 1995;36(6):935-8.
-
1995: Lacerda M A; Ludwig J; Dickson E R; Jorgensen R A; Lindor K D
Antimitochondrial antibody-negative primary biliary cirrhosis.
The American journal of gastroenterology 1995;90(2):247-9.
-
1995: Lindor K D; Janes C H; Crippin J S; Jorgensen R A; Dickson E R
Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?
Hepatology (Baltimore, Md.) 1995;21(2):389-92.
-
1994: Laurin J M; DeSotel C K; Jorgensen R A; Dickson E R; Lindor K D
The natural history of abdominal pain associated with primary biliary cirrhosis.
The American journal of gastroenterology 1994;89(10):1840-3.
-
1994: Balan V; Dickson E R; Jorgensen R A; Lindor K D
Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.
Mayo Clinic proceedings. Mayo Clinic 1994;69(10):923-9.
-
1994: Lindor K D; Dickson E R; Baldus W P; Jorgensen R A; Ludwig J; Murtaugh P A; Harrison J M; Wiesner R H; Anderson M L; Lange S M
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Gastroenterology 1994;106(5):1284-90.
-
1994: Crippin J S; Jorgensen R A; Dickson E R; Lindor K D
Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.
The American journal of gastroenterology 1994;89(1):47-50.
-
1992: Crippin J S; Lindor K D; Jorgensen R; Kottke B A; Harrison J M; Murtaugh P A; Dickson E R
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?
Hepatology (Baltimore, Md.) 1992;15(5):858-62.
-
1990: Wiesner R H; Ludwig J; Lindor K D; Jorgensen R A; Baldus W P; Homburger H A; Dickson E R
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis.
The New England journal of medicine 1990;322(20):1419-24.
Sign-in to see more
